Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Samsung
Elon Musk
Google
Space News
Motorola
Android 13
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Technology News / Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial
Technology

Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial

Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial
Written by Shubham Sharma
May 08, 2020, 08:53 pm 3 min read
Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial

Moderna Therapeutics, one of the select few companies trialing a COVID-19 vaccine, has received US Food and Drug Administration's approval to move into the second phase of the tests. The company announced that its vaccine candidate has been cleared for the next stage of human trials, which will begin shortly, ultimately paving the way to bring it into the market. Here's all about it.

Trial
Phase 2 to test the vaccine with more volunteers

In the phase 1 trial, the experimental vaccine, which was developed jointly by researchers at Moderna and the National Institutes of Health, was tested on 45 volunteers - in different doses - over the course of six weeks. Now, in the mid-stage study, the company will expand the trial and test the potential solution with 600 healthy adults.

Trial results
Results expected in third quarter

While Moderna did not share the exact timeline for the phase 2 trial, it did say that the study would begin shortly, with results expected in June-July. Then, provided all goes according to the plan, the company hopes to start phase 3 of human trials in summer itself, lining up the vaccine for approval for public use in early 2021.

Information
All three phases are aimed at determining efficacy, safety

Notably, both upcoming trials of the experimental vaccine are aimed at determining its effectiveness in neutralizing the novel coronavirus as well as establishing its safety for widespread public use.

Manufacturing
Partnership with Lonza to manufacture the vaccine

Along with the trials, Moderna is also moving to set up manufacturing so that sufficient doses are available for distribution if their candidate gets necessary approvals. The company has already partnered with Swiss drugmaker Lonza for this purpose and is planning to start manufacturing as early as July, just when it expects to move towards phase 3 of trials.

Quote
A billion doses every year targeted, says CEO Stephane Bancel

"We are accelerating manufacturing scale-up and our partnership with Lonza puts us in a position to make and distribute as many doses as possible, should it prove to be safe and effective," CEO said, noting the company hopes to deliver a billion doses every year.

Working
How this vaccine works?

Typically, vaccines for viral diseases carry a weakened/killed strain of the virus that causes the disease. But, this one, officially dubbed mRNA-1273, doesn't carry the coronavirus causing COVID-19; instead, it uses a short segment of genetic code copied from the virus, which primes the immune system to detect and fight the actual infection. The team says it has been developed with a tried-and-tested process.

Information
Other promising vaccine in clinical trial

In addition to Moderna, a few more organizations are carrying out human trials of COVID-19 vaccines, including Oxford University. The institute says its solution could become publicly available by September-October or 3-4 months sooner than all other vaccines currently being developed/tested.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shubham Sharma
Shubham Sharma
Twitter
Editor with over five years of experience in covering all things science, consumer tech, space tech, AI, infosec, and business. A commerce graduate from University of Lucknow. I have been handling Tech beat at NewsBytes since 2018.
Latest
Oxford University
National Institutes of Health
COVID-19
Moderna Therapeutics
Moderna Inc
Latest
Shah Rukh's 'Dunki': Next schedule to be shot in Dubai
Shah Rukh's 'Dunki': Next schedule to be shot in Dubai Entertainment
Ladies, here are 5 must-have jeans that you should score
Ladies, here are 5 must-have jeans that you should score Lifestyle
Mohammed Siraj to represent Warwickshire in County Championship: Details here
Mohammed Siraj to represent Warwickshire in County Championship: Details here Sports
5 important facts to know before watching MCU's 'She-Hulk'
5 important facts to know before watching MCU's 'She-Hulk' Entertainment
Apple iPhone 14's launch may take place on September 7
Apple iPhone 14's launch may take place on September 7 Technology
Oxford University
COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll
COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll World
AstraZeneca vaccine's single dose reduces death risk by 80%: Data
AstraZeneca vaccine's single dose reduces death risk by 80%: Data World
#OxfordUniversity racism row: India to raise the issue when required
#OxfordUniversity racism row: India to raise the issue when required India
Five killed in Serum Institute fire; Maharashtra government orders probe
Five killed in Serum Institute fire; Maharashtra government orders probe India
Maldives to become first foreign country to receive Covishield doses
Maldives to become first foreign country to receive Covishield doses World
More News
National Institutes of Health
Immune response induced by COVID-19 can seriously damage brain: Study
Immune response induced by COVID-19 can seriously damage brain: Study World
Convalescent plasma therapy doesn't stop COVID-19 progression: NIH
Convalescent plasma therapy doesn't stop COVID-19 progression: NIH Technology
Over 1.5 million children lost caregivers to COVID-19 worldwide: Report
Over 1.5 million children lost caregivers to COVID-19 worldwide: Report World
US clears Pfizer coronavirus vaccine, first shot in 24 hours
US clears Pfizer coronavirus vaccine, first shot in 24 hours World
US expert offers an optimistic timeline for coronavirus vaccine
US expert offers an optimistic timeline for coronavirus vaccine World
More News
COVID-19
Can't pretend COVID-19 is gone: WHO chief on rising cases
Can't pretend COVID-19 is gone: WHO chief on rising cases World
Bharat Biotech completes third-phase of intranasal COVID-19 vaccine trials
Bharat Biotech completes third-phase of intranasal COVID-19 vaccine trials India
Congress chief Sonia Gandhi tests COVID-19 positive again
Congress chief Sonia Gandhi tests COVID-19 positive again Politics
With 2,726, Delhi reports highest COVID-19 cases in 7 months
With 2,726, Delhi reports highest COVID-19 cases in 7 months India
Delhi makes masks mandatory, Rs. 500 fine imposed on violators
Delhi makes masks mandatory, Rs. 500 fine imposed on violators Delhi
More News
Moderna Therapeutics
Moderna's COVID-19 vaccine found to be 95% effective: Details here
Moderna's COVID-19 vaccine found to be 95% effective: Details here Technology
Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial
Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial India
Chinese hackers targeted COVID-19 vaccine maker Moderna: Report
Chinese hackers targeted COVID-19 vaccine maker Moderna: Report World
Moderna's COVID-19 vaccine goes into final human trial stage
Moderna's COVID-19 vaccine goes into final human trial stage World
NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap
NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap Technology
More News
Moderna Inc
Moderna COVID-19 vaccine produces lasting immune response: Study
Moderna COVID-19 vaccine produces lasting immune response: Study Technology
Japan suspends 1.63mn Moderna vaccine doses after contamination found
Japan suspends 1.63mn Moderna vaccine doses after contamination found World
No sign of Pfizer, Moderna vaccines in breast milk: Study
No sign of Pfizer, Moderna vaccines in breast milk: Study Technology
India offered 7.5mn doses of Moderna vaccine under COVAX program
India offered 7.5mn doses of Moderna vaccine under COVAX program India
Moderna vaccine arriving in India in 2-3 days: Report
Moderna vaccine arriving in India in 2-3 days: Report India
More News
Next News Article
Next News Article

Love Technology news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022